Skip to main content
. 2022 Jul 30;2022:6726438. doi: 10.1155/2022/6726438

Table 3.

In vitro anti-diabetic inhibitory activity of the synthesized compounds.

Compound IC50 (μM) IC50 (μM)
MSJ1 149.35 144.48
MSJ2 94.73 86.46
MSJ3 173.89 93.01
MSJ4 96.90 84.99
MSJ5 50.98 27.29
MSJ6 155.59 127.34
MSJ7 64.87 55.62
MSJ8 113.38 76.26
MSJ9 32.00 27.24
MSJ10 28.04 16.62
Acarbose 9.76 3.86